ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]
15
Nov
Nov
Medicare coverage for patients meeting certain criteria to begin as of December 30, 2019 MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019. Full text of the […]
01
Aug
Aug
BioReference to Provide Diagnostic Test Services and Assist with Patient-Centered Data Analytics ELMWOOD PARK, NJ. (August 1, 2019) – BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA Association of America (TIPAAA) as its preferred provider of laboratory services and to assist with data […]
01
Jul
Jul
BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers SOMOS, New York City’s Largest Multi-Cultural Physician-Led Network Selects BioReference as Preferred Provider for Diagnostic Testing MIAMI, FL., July 01, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., an OPKO Health (NASDAQ: OPK) company and one of the largest clinical laboratories in the United States, has been selected […]
Proposed LCD will allow Medicare coverage within criteria for the 4Kscore® Test MIAMI, June 28, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination (LCD) for the 4Kscore® test, with defined coverage criteria. Under the LCD, Medicare will reimburse the test for patients who […]
07
Jun
Jun
Complimentary PSA Testing Provided to Participants of Annual Golf Tournament ELMWOOD PARK, June 7 – BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of Man Cave Health’s upcoming charity golf tournament for Men’s Health Month, observed annually in the United States during the month of June. The event will […]
17
May
May
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).
02
May
May
ELMWOOD PARK, N.J., May 2, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment programs at the 2019 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Nashville, Tennessee from May 3-6. The […]
Executive chairman Dr. Cohen recently spoke with Dr. Oz and New York Times journalist, John Carreyrou, about attempting 70+ tests on a single drop of blood. BioReference Phlebotomy Training Specialist, June Daves, also appeared and drew 6 vials of Dr. Oz’s blood. In case you missed the appearance, you can view a clip from this […]
22
Apr
Apr
ELMWOOD PARK, NJ, April 22, 2019 – BioReference Laboratories Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it will gain preferred laboratory network provider status for UnitedHealthcare. The contract includes BioReference’s subsidiary GeneDx, a full service genetics laboratory. Learn about the UnitedHealthcare Preferred Lab Network here. “At BioReference we are committed to making […]
